D Wierda
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
- Immunology top 10%
- Biosimilars and Bioanalytical Methods
- Immunotoxicology and immune responses
Papers in ⓘ
-
- Immunotoxicology and immune responses 3
- Biosimilars and Bioanalytical Methods 3
-
- Hematopoietic Stem Cell Transplantation 4
- Co-authors
- Kevin W. Gaido (2 shared papers)Angela G. King (3 shared papers)Kenneth S. Landreth (3 shared papers)David Siegel (2 shared papers)David Ross (2 shared papers)Mark J. Reasor (2 shared papers)Holly W. Smith (3 shared papers)Rafael Ponce (1 shared paper)
- Journals
- Toxicology and Applied Pharmacology (4 papers)Toxicological Sciences (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Molecular Pharmacology (2 papers)Human & Experimental Toxicology (2 papers)
- Partner nations
- United StatesUnited KingdomSweden
In The Last Decade
D Wierda
20 papers receiving 570 citations
Peers
Comparison fields: 5 of 81
- Toxicology 68
- Immunology 247
- Cancer Research 131
- Small Animals 47
- Radiology, Nuclear Medicine and Imaging 122
Countries citing papers authored by D Wierda
This map shows the geographic impact of D Wierda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Wierda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Wierda more than expected).
Fields of papers citing papers by D Wierda
This network shows the impact of papers produced by D Wierda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Wierda. The network helps show where D Wierda may publish in the future.
Co-authors
The 25 scholars most cited alongside D Wierda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 179 | |
| 2 | 1990 | 72 | |
| 3 | 1981 | 60 | |
| 4 | 1987 | 57 | |
| 5 | 1988 | 53 | |
| 6 | 1984 | 51 | |
| 7 | 1990 | 41 | |
| 8 | 1987 | 22 | |
| 9 | 1989 | 19 | |
| 10 | Immunogenicity of biosynthetic human LysPro insulin compared to native-sequence human and purified porcine insulins in rhesus monkeys immunized over a 6-week period. | 1995 | 14 |
| 11 | 1979 | 6 | |
| 12 | 1987 | 4 | |
| 13 | 1984 | 3 | |
| 14 | 2000 | 3 | |
| 15 | 1991 | 2 | |
| 16 | 1996 | 2 | |
| 17 | Mouse bone marrow stromal cells can accumulate and release cytotoxic concentrations of doxorubicin into the hematopoietic microenvironment | 1993 | 2 |
| 18 | 2000 | 1 | |
| 19 | 2016 | 1 | |
| 20 | Reduction of progenitor b-lymphocytes in mice after hydroquinone and catechol administration. Abstr. | 1981 | 1 |
About D Wierda
D Wierda is a scholar working on Immunology, Hematology, Oncology, Molecular Biology and Cancer Research, having authored 20 papers that have together received 593 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (4 papers), Immunotoxicology and immune responses (3 papers), Biosimilars and Bioanalytical Methods (3 papers), Bioactive Compounds and Antitumor Agents (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Carcinogens and Genotoxicity Assessment (3 papers), Cancer therapeutics and mechanisms (2 papers) and Synthesis and Biological Evaluation (2 papers). The work is most often cited by research in Toxicology (68 citations), Immunology (247 citations), Cancer Research (131 citations), Small Animals (47 citations) and Radiology, Nuclear Medicine and Imaging (122 citations). D Wierda has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include Kevin W. Gaido, Angela G. King, Kenneth S. Landreth, David Siegel, David Ross, Mark J. Reasor, Holly W. Smith, Rafael Ponce, Shalini Gupta and Vangala V. Subrahmanyam. Their work appears in journals such as Toxicology and Applied Pharmacology, Toxicological Sciences, Journal of Pharmacology and Experimental Therapeutics, Molecular Pharmacology and Human & Experimental Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.